Phase II Drug Trial

If you are interested in participating in this study, please click the button below to see if you qualify:

Apply Now

Please note that any information provided will not be sold to any third party and will be kept private.
We may, however, contact you regarding any future studies. You may opt out at any time.

Drug Trial Information:

We are currently part of a multi-center double-blinded controlled drug trial that is studying the effects of a medication that can help diffuse pain secondary to Mast Cell Activation Syndrome.

We are looking for volunteers to participate in this Phase II drug trial. Please see below for additional details!

What is Mast Cell Activation Syndrome:

Mast Cell Activation Syndrome, or MCAS, is a condition in which a patient suffers from various allergic reactions, and the cells that are released during these episodes are mast cells. The mediators within the mast cells are released in higher than normal quantities, and happen without any clear indication.

Patients with MCAS often have diffuse pain as well as other systemic conditions (hives, dermatographia, diarrhea, tachycardia, shortness of breath, nausea, etc.). By addressing the mast cells, diffuse pain can reduce.

Participant Information

Each person participating in this study will be asked to be a part of a drug trial, in which you will be taking medication for two months, with consistent follow-up (in person and over the phone, along with filling in questionnaires online) required.

Participants with be compensated up to $50 for meals and transportation each time you travel to our center.

Patients must be able to come to our office for frequent visits (6 visits in total), be between the ages of 18 and 75, and be in general good health. Female participants may not be pregnant or breastfeeding at the time of study.

All information provided will be kept strictly confidential. 

If you are interested in participating in this study, please click the button below to see if you qualify:

Apply Now

Please note that any information provided will not be sold to any third party and will be kept private.
We may, however, contact you regarding any future studies. You may opt out at any time.